Results 41 to 50 of about 10,572,916 (223)

Comparison of immunoresponse in PHB, YHB-vaccinee, and immunological background of non-responder.

Kanzo, 1990
B型肝炎ウイルスの院内感染予防を目的として医療従事者1,736名を対象に,人血漿由来HBワクチン(PHB vaccine)と遺伝子組替え酵母由来HBワクチン(YHB vaccine)の2種のワクチン接種を行い,その成績を比較した.併せてPHBワクチン接種群の抗体価の推移,および無反応例について細胞性免疫能を検討した.HBs抗体陽転率および獲得抗体価の対比では,PHBワクチン接種群の抗体陽転率は86%に留まったが,獲得抗体価は平均CI 97, (RIA法)であったのに対して,YHBワクチン接種群の陽転率は99%と高率であったが,獲得抗体価は平均CI 39, (RIA法)と低値であった.PHBワクチン接種群203例の抗体価の推移ほ9ヵ月後に平均55%の低下率を示した ...
TAKEUCHI, Naoko, HOSHI, Yasutaka, FUJISAWA, Kiyoshi   +2 more
openaire   +2 more sources

DOMS intensity in responders and non-responders.

, 2022
DOMS intensity in responders and non-responders.
Einat Kodesh (13132997), Irit Weissman-Fogel (325810), Tsipora Mankovsky-Arnold (13133003), Simone Shamay-Tsoory (5076887), Anat Sirkis-Gork (13133000)   +4 more
core   +1 more source

Eradication of Helicobacter pylori can facilitate immune reconstitution in HIV-1-infected immunological non-responders [PDF]

International Journal of Infectious Diseases, 2010
A significant number of HIV-1 patients experience poor immune reconstitution despite long-term viral suppression with highly active antiretroviral therapy (immunological non-responders). The aims of the present study were to determine whether eradication of Helicobacter pylori could facilitate a better immune reconstitution in these patients.Forty-nine
Magen, Eli, Elbirt, Daniel, Agmon-Levin, Nancy, Mishal, Joseph, Sthoeger, Zev   +4 more
openaire   +2 more sources

Increased early activation of CD56dimCD16dim/- natural killer cells in immunological non-responders correlates with CD4+ T-cell recovery. [PDF]

Chin Med J (Engl), 2020
Abstract Background Natural killer (NK) cells play a critical role in suppressing human immunodeficiency virus-1 (HIV-1) infection, but knowledge on whether and how NK cells affect immune reconstitution in HIV-1-infected individuals who receive antiretroviral therapy (ART) is limited.
Zhang QY, Zhang X, Su B, Liu LF, Yang XD, Tang B, Xia H, Ma P, Zhang T, Wu H.   +9 more
europepmc   +4 more sources

Demographic characteristics of responders and non-responders.

, 2021
Demographic characteristics of responders and non-responders.
Katja Stahl (4994483), Oliver Groene (4538485)   +1 more
core   +1 more source

Severe non AIDS-related events observed during the follow-up (overall results and stratified by immunological response at year 1).

, 2015
List of abbreviations: AIDS, acquired immunodeficiency syndrome; eGFR, estimated glomerular filtration rate; INR, immunological non-responders; IR, Immunological responders.Severe non AIDS-related events observed during the follow-up (overall results and
Massimo Di Pietro (237801), Franco Maggiolo (372561), Liliane Chatenoud (746686), Francesco Castelli (746687), Giuseppe Lapadula (554894), Andrea Gori (62770), Angelo Pan (554895), Simona Di Giambenedetto (238433), Emanuele Focà (485005), Nicoletta Ladisa (237795), Laura Sighinolfi (237791), Carlo Torti (237805), Massimiliano Fabbiani (239073)   +12 more
core   +1 more source

Implications of accumulation of clonally expanded and senescent CD4⁺GNLY⁺ T cells in immunological non-responders of HIV-1 infection. [PDF]

Emerg Microbes Infect
Increased CD4+GNLY+ T cells have been confirmed to be inversely associated with CD4+ T cell count in immunological non-responders (INRs), however, the underlying mechanisms are unknown. This study aimed to elucidate the characteristics of CD4+GNLY+ T cells and their relationship with immune restoration.
Yang X, Zhen C, Huang H, Jiao Y, Fan X, Zhang C, Song J, Wang S, Zhou C, Yang X, Yuan J, Zhang J, Xu R, Wang FS.   +13 more
europepmc   +4 more sources

Immunological Review on Non-responder Phenomenon to Hepatitis B Vaccination

Cermin Dunia Kedokteran
Hepatitis B vaccine has been highly effective in preventing HBV infection. However, a subset of individuals fails to develop adequate protective antibodies after complete vaccination series (anti-HBs ≥ 10 mIU/mL), termed as non-responders. Non-responder phenomenon is influenced by a complex interplay of genetic, immunological, and environmental factors.
Adika Zhulhi Arjana, Ninda Devita
openaire   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin, Sheila K. Pierson, Kelley C. Dacus, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Larissa Borys, Kayla McHugh, Abiola Irvine, Yoojin Jo, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum, Joshua D. Brandstadter   +17 more
wiley   +1 more source

Responders vs. non-responders.

, 2016
Responders vs. non-responders.
Leonid Goubergrits (147403), Eckart Fleck (114516), Sebastian Kelle (114520), Titus Kuehne (2579659), Adelina Doltra (2579656), Arthur Hartmann (2579662), Murray Esler (491549), Ernst Wellnhofer (442512), Christopher Schneeweis (114493), Bernhard Schnackenburg (114494), Philipp Stawowy (442513), Rolf Gebker (114506)   +11 more
core   +1 more source